Clinical Research |
From Alfred and Baker Medical Unit (K.J.W., A.M.D., J.C.-D.), Wynn Domain, Baker Heart Research Institute, Melbourne, Australia; Australian Centre for Blood Disease (S.K., S.J.), Monash University, Melbourne, Australia; F-Hoffman La Roche (D.K.), Basel, Switzerland.
Correspondence to K. J. Woollard, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, 8008, Australia. E-mail Kevin.Woollard{at}baker.edu.au
Raised levels of soluble P-selectin (sP-selectin) have been reported in the plasma of patients with vascular diseases; however, the functional importance of this ligand remains unclear. In this study we have examined a potential role for plasma sP-selectin in regulating neutrophil adhesion in patients with peripheral arterial occlusive disease (PAOD). Patients with PAOD had significantly higher levels of sP-selectin (mean±SD: 73.3±13.0 versus 16.7±6.4 ng/mL) and enhanced whole blood leukocyte adhesion to platelets under shear. To examine whether the raised sP-selectin levels can directly influence leukocyte adhesion, isolated neutrophils were incubated with plasma from PAOD patients before and after immunodepletion of sP-selectin. Neutrophil adhesion to fibrinogen increased 2-fold following incubation with PAOD plasma, which was abrogated on sP-selectin immunodepletion. We subsequently demonstrated that recombinant sP-selectin dose-dependently (75 to 250 ng/mL) increased leukocyte adhesion to fibrinogen and platelet monolayers. This increase was PSGL-1 and Src kinase-dependent and correlated with an increase in sP-selectin-mediated Mac-1 activation. sP-selectinstimulated neutrophil adhesion to platelet monolayers was inversely correlated with shear, such that at low shear (50 s1) a 92.7%±15.7 increase in adhesion was observed decreasing to 38.5%±11.9 at 150 s1 and 10.1%±7.4 at 300 s1. These studies suggest a potentially important role for sP-selectin in modulating neutrophil adhesion in patients with PAOD, particularly at sites of low shear, where it raises the possibility that raised plasma sP-selectin levels may enhance leukocyte recruitment to vascular injury and promote disease progression.
Key Words: atherosclerosis cell adhesion molecules leukocytes peripheral vascular disease
Related Article:
Circ. Res. 2006 98: 12-14.
This article has been cited by other articles:
![]() |
D. D. Wagner and P. S. Frenette The vessel wall and its interactions Blood, June 1, 2008; 111(11): 5271 - 5281. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Rao, L. Yang, G. Garcia-Cardena, and F. W. Luscinskas Endothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall Circ. Res., August 3, 2007; 101(3): 234 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Galkina and K. Ley Double Jeopardy: How Soluble P-Selectin Activates Leukocytes in Peripheral Arterial Occlusive Disease Circ. Res., January 6, 2006; 98(1): 12 - 14. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |